THY1 and Cognitive impairment: Our in vivo results are partially in line with those of a previous study by Subramaniam and colleagues that investigated the effects of nicotine treatment in tg mice overexpressing human α-Syn under the Thy-1 promoter and reported improvement of cognitive impairment after chronic nicotine treatment (Subramaniam et al., 2018).